Join the Oncology Voice Network. Join for Free
Tips for landing your first MSL role…From a guy who just did with Kyle Householder
Medical Science Liaison MSL career tips landing first MSL role networking for MSLs resume tips for MSLs

Tips for landing your first MSL role…From a guy who just did with Kyle Householder


Share This Article


Summary

My guest today is Kyle Householder, Medical Science Liaison at Teva Pharmaceuticals and we discuss how he landed his first MSL role and tips for anyone out there looking to do the same.

In this episode:

  • What is the first thing to do on the journey to landing an MSL role
  • What’s next after landing the MSL role
  • Networking Do’s and Don’ts
  • Kyle’s suggestions on resumes and cover letters
  • What Tom thinks is important to add on resumes 
  • Kyle’s advice to aspiring MSLs

Click for Source
Medical Science Liaison, MSL career tips, landing first MSL role, networking for MSLs, resume tips for MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Explore OVN